Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,738 GBX | -0.11% | -3.02% | +19.60% |
May. 28 | CureVac, GSK Begin Dosing in Phase 2 Study for Seasonal Influenza Vaccine Candidate | MT |
May. 27 | US, European nations consider vaccinating workers exposed to bird flu | RE |
MarketScreener Strategies
Filters
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- MarketScreener Strategies